Cardiovascular Systems Presents Key LIBERTY 360° Demographic Data In Late-Breaking Presentation At The 28th International Symposium On Endovascular Therapy

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems (CSI) (NASDAQ: CSII) presented key baseline demographic data from its LIBERTY 360° post-market study in a late-breaking presentation at the 28th International Symposium on Endovascular Therapy (ISET) in Hollywood, Fla. The study completed its enrollment on Feb. 1, 2016, and will evaluate the acute and long-term clinical and economic outcomes of endovascular device interventions, including CSI’s orbital atherectomy system, in treating peripheral arterial disease (PAD).